Hsu Frank J. 4
4 · Oncternal Therapeutics, Inc. · Filed Mar 18, 2020
Insider Transaction Report
Form 4
Hsu Frank J.
Chief Medical Officer
Transactions
- Award
Stock Option
2020-03-17−16,280→ 16,280 totalExercise: $3.33Exp: 2030-03-17→ Common Stock (16,280 underlying)
Footnotes (1)
- [F1]Fully vested on grant date.